Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.
Minh Tung PhungAlice W LeeAnna H WuAndrew BerchuckKathleen R ChoDaniel W CramerJennifer Anne DohertyMarc T GoodmanGillian E HanleyHolly R HarrisKaren McLeanFrancesmary ModugnoKirsten B MoysichBhramar MukherjeeJoellen M SchildkrautKathryn L TerryLinda J TitusSusan J JordanPenelope M WebbMalcolm C PikeCeleste Leigh Pearcenull nullnull nullnull nullPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
The results of this study are of particular interest given the rise in popularity of progestin-releasing intrauterine devices that have a substantially lower progestin dose than that in DMPA, but may have a stronger local effect.
Keyphrases